Consumer behavioral systems to approach or avoid generic medicine (GM) consumption in Japan
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Hosoda, T. | - |
dc.contributor.author | Fraser, J.R. | - |
dc.contributor.author | Kim, M.-S. | - |
dc.contributor.author | Cheon, H.J. | - |
dc.date.available | 2019-03-13T01:44:27Z | - |
dc.date.created | 2018-10-18 | - |
dc.date.issued | 2018-05 | - |
dc.identifier.issn | 2288-4637 | - |
dc.identifier.uri | http://scholarworks.bwise.kr/ssu/handle/2018.sw.ssu/31651 | - |
dc.description.abstract | Generic medicine (GM), which is an alternative drug product for branded medicine (BM), is used less in Japan than in other OECD countries. Therefore, we investigate why the medical consumers of Japan avoid the use of GMs even though the efficacy and safety of the medicines have already been proven. We theorize that effectiveness or risk of GMs are related to the consumer attitude toward GMs is affected by the behavioral approach/activation system (BAS) which promotes actions to reach the desired state, and the behavioral inhibition system (BIS) which suppresses behaviors to avoid negative outcomes. To see which of the BAS and BIS dimensions are related to GM usage, we surveyed 374 Japanese consumers and found that Quality, Efficacy, Safety, & Cost-effectiveness with the BAS, and Functional Risk, Financial Risk, Social Risk, Physical Risk, Psychological Risk, & Time Risk with the BIS had a significant effect on consumer attitude to GMs. These results are important in that they 1), confirm the role of BAS/BIS in attitudes to GMs, 2), provide guidelines when marketing GMs, 3), help governments promote the use of GMs as a cost-saving measure, and 4), guide future surveys regarding consumer attitudes to GMs. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | Korea Distribution Science Association (KODISA) kodisajournals@gmail.com | - |
dc.relation.isPartOf | Journal of Asian Finance, Economics and Business | - |
dc.title | Consumer behavioral systems to approach or avoid generic medicine (GM) consumption in Japan | - |
dc.type | Article | - |
dc.identifier.doi | 10.13106/jafeb.2018.vol5.no2.105 | - |
dc.type.rims | ART | - |
dc.identifier.bibliographicCitation | Journal of Asian Finance, Economics and Business, v.5, no.2, pp.105 - 118 | - |
dc.identifier.kciid | ART002350592 | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000446927800011 | - |
dc.identifier.scopusid | 2-s2.0-85053413841 | - |
dc.citation.endPage | 118 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 105 | - |
dc.citation.title | Journal of Asian Finance, Economics and Business | - |
dc.citation.volume | 5 | - |
dc.contributor.affiliatedAuthor | Cheon, H.J. | - |
dc.identifier.url | http://jafeb.org/journal/article.php?code=61560 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | N | - |
dc.description.oadoiVersion | published | - |
dc.subject.keywordAuthor | BAS | - |
dc.subject.keywordAuthor | BIS | - |
dc.subject.keywordAuthor | Branded medicine | - |
dc.subject.keywordAuthor | Generic medicine | - |
dc.subject.keywordAuthor | Second-order factor analysis | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Soongsil University Library 369 Sangdo-Ro, Dongjak-Gu, Seoul, Korea (06978)02-820-0733
COPYRIGHT ⓒ SOONGSIL UNIVERSITY, ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.